In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

The second Trump administration posted its National Security Strategy to the White House site late Thursday. Read the 33-page document, which is required by Congress but does not necessarily bind ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

Those pesky glitches that occasionally interrupt your video calls may be more than just an annoyance — they could undermine your success in everything from job interviews to sales pitches to court ...

Recursion Pharmaceuticals' work could change the way that drugs are developed. Its pipeline features some exciting candidates, and it's partnering with major drugmakers. However, Recursion still needs ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

For decades, David Kelley has helped people unlock their creativity. A pioneer of design, he founded the Stanford d.school as a place for creative, cross-disciplinary problem solving. He reflects on ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

Microsoft announced a new educational initiative called "Java and AI for Beginners: A Practical Video Series for Java," offering a structured introduction for Java developers interested in generative ...

WWE shared a new video on their X on Sunday morning, seemingly teasing the return of a significant star to the ring or their various shows. The brief video features some ominous music and a shot of ...